| 参麦注射液治疗无症状性冠心病的疗效观察 |
| |
| 引用本文： | 万年青.参麦注射液治疗无症状性冠心病的疗效观察[J].中成药,1998,20(6):27-28. |
| |
| 作者姓名： | 万年青 |
| |
| 作者单位： | 浙江乐清市人民医院!325600 |
| |
| 摘 要： | 参麦注射液是由人参、麦冬中药复方提取精制而成的注射液。临床观察治疗无症状性冠心病26例，结果表明，参麦注射液能明显改善无症状性冠心病的ST-T改变，其作用优于对照药物消心痛，诊疗期间未见毒副作用。
|
| 关 键 词： | 参麦注射液 冠心病 无症状性 临床治疗 |
Investigation of Clinical Curative Effect of Shenmai Injection(Radix Ginseng,Radix Ophiopogonis,etc)for Symptomless Coronary Heart Disease |
| |
| Wan Nianqing.Investigation of Clinical Curative Effect of Shenmai Injection(Radix Ginseng,Radix Ophiopogonis,etc)for Symptomless Coronary Heart Disease[J].Chinese Traditional Patent Medicine,1998,20(6):27-28. |
| |
| Authors: | Wan Nianqing |
| |
| Abstract: | Shenmai injection, composed of Radix Ginseng, Radix Ophiopogonis, etc. is clinicallyused for the treatment of symptomless coronary heart disease on 26 cases. As a result, itcould improve the ST-T change of symptomless coronary heart disease. This action is superior to that of the control drug isosorbide nitrate. No toxicity and side-effect are observed during treatment course. |
| |
| Keywords: | Shenmai Injection symptomless coronary heart disease clinical application |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
